
Opinion|Videos|August 20, 2024
Key Takeaways for Biosimilar Utilization
The panelists provide their closing thoughts, highlighting key considerations around biosimilar.
Advertisement
Episodes in this series

Video content above is prompted by the following:
Thanks to all of you for this rich and informative discussion. Before we conclude I’d like to get final thoughts from each of you…
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants
2
Clinician Shortages, Access Gaps Challenge Rural Primary Care
3
Diet, Lifestyle Come Into Focus for Managing Multiple Sclerosis: Rebecca Spain, MD
4
Challenges to NGS Testing for Follicular Lymphoma in the Community Setting
5













































